相关实验视频

Updated: Jun 9, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Bag2通过维持Pink1介导的线粒细胞衰变来防止多克索鲁比引起的心脏毒性

Hongkai Xiao¹, Siyu Liang¹, Qinhong Cai¹

¹The Fourth Affiliated Hospital, Guangzhou Medical University, China.

|October 23, 2024

概括

Bag2 (BCL2关联的乙二) 通过维持线粒细胞衰变,保护免受多克索鲁比诱导的心脏毒性. 过度表达Bag2可保持线粒体功能并减少心肌损伤,这表明它是化疗副作用的治疗点.

科学领域:

生物化学生物化学
心脏病学心脏病学
分子生物学分子生物学

背景情况:

多克索鲁比 (DOX) 化疗会引起心脏毒性,这是一个主要的临床限制.
线功能障碍被确定为DOX诱导心脏毒性 (DIC) 的主要机制.
特定的分子机制,通过DOX影响线粒细胞衰变并未完全理解.

研究的目的:

为了研究 Bag2 (BCL2 相关的乙醇基因 2) 在 DIC.中潜在的心脏保护作用.
在DOX处理的背景下,阐明Bag2影响线粒细胞衰变的机制.

主要方法:

在C57BL/6小鼠和AC16细胞中建立了DIC模型.
使用西式涂抹和免疫组织化学量化Bag2表达.
进行功能增益和功能丧失实验,以评估Bag2对DIC表型的影响.

主要成果:

在体外和体内, doxorubicin 治疗显著降低了 Bag2 表达.
阻断Bag2或DOX的使用导致了细胞亡,线粒体功能障碍和线粒体的受损.
过度表达Bag2改善了DOX诱导的心脏毒性,保持线粒体功能并减少心肌损伤.

结论:

Bag2通过稳定Pink1对蛋白质体降解起到关键作用,维护 mitophagy激活.
Bag2过度表达显示出对DIC的显著心脏保护作用.
Bag2 是一个潜在的治疗点,可以缓解多克索鲁比诱导的心脏毒性.

关键词:

包2袋2袋2袋2袋2袋2袋2袋心脏有毒性 - 心脏有毒性德克索鲁比辛是一种多克索鲁比辛.线粒细胞衰变 (mitophagy) 是一种细胞衰变的过程.

更多相关视频

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...